New Tests Launched in October - Insights
In October 2017, Mayo Medical Laboratories announced eight new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Sarcoma Testing - Mayo Clinic Laboratories
Supplementing the histologic diagnosis with genetic testing can improve diagnostic accuracy and overall patient management.
Magically improving the patient experience - Insights
This "Phlebotomy Webinar" will enhance the user’s knowledge regarding how the secrets of magicians can be used to reduce patient fear and anxiety associated with hospital and clinic visits. Attendees will be provided with research studies...
Lung Cancer PDL1 Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories offers three PD-L1 clones for assessing patient response to specific therapies.
Single Gene Sarcoma Testing - Mayo Clinic Laboratories
In cases where comprehensive NGS analysis cannot be performed or the diagnosis is highly suspect, we also offer a variety of single-gene fluorescence in situ hybridization (FISH) tests
How to grow your career in outreach management - Insights
On this episode of Mayo Clinic Laboratories “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, sits down with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton to...
See how our unique panel includes testing for antibodies proven to be associated with paraneoplastic or cancer-associated retinopathy.
Ethical Issues in Phlebotomy - Insights
This "Phlebotomy webinar" will discuss ethical issues frequently faced by phlebotomists.
Find out how our sarcoma panel assesses gene mutations and fusions described in more than 50 types of soft tissue, bone, and other mesenchymal tumors.
Browse our suite of fluorescence in situ hybridization tests designed to identify malignancies in select genes associated with eosinophilia.